Schedule 13G ownership disclosure

OncBioMune Pharmaceuticals, Inc

Security class unavailable · CUSIP: 68235A101

Event date: 2015-09-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001520138-16-000752
Form type
SC 13G/A
Filer
Ehrlich Barrett
CIK
CIK 1622858
Filed
Mar 02, 2016
Reporting period
Sep 02, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub